FOXP3 and diabetes mellitus: Here, we show that anti-CD3 mAb therapy in Treg cell-depleted NOD.DEREG mice potently interfered with diabetes development (Figures 3E, F), probably by mechanisms independent of Foxp3+ Treg cells.